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Abstract
The hippocampus is an elongated brain structure related to processing episodic memory
and spatial navigation. The dorsal hippocampus plays an important role in spatial tasks (Lee &
Kesner, 2003), while the ventral hippocampus is known to be involved with emotion (Fanselow
& Dong, 2010). Previous work in our lab has shown that the dorsal and ventral sections within
the same hemisphere work together during navigation (Lee et al., 2019). The lab is currently
determining how activity in the dorsal hippocampus impacts place cell firing in the ventral
hippocampus. To accomplish this the dorsal hippocampus will be inactivated using Designer
Receptors Exclusively Activated by Designer Drugs (DREADDs).
To examine the impact of dorsal hippocampus inactivation, we analyzed the performance
of rats in a spatial working memory version of the Morris Water Maze. Latency and swim path
to the platform were compared under conditions with and without DREADD activation. It was
found that there were no differences in spatial navigation abilities when the rats received vehicle
or drug injections. Histological analysis showed that the initial DREADDs surgery was
unsuccessful, explaining this finding.

Introduction
Spatial navigation and the ability to remember the location of a reward are complex
behaviors. An organism needs to orient itself and understand the spatial relations between
objects. A common way to analyze an organism’s understanding of the space around them is
through the use of experimental escape procedures. Within these tasks, animals are placed
within an unfavorable environment and forced to use either local/non-spatial or extramaze/spatial cues to locate a safe space and remove themselves from the unfavorable condition
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(Terry, 2009). The Morris Water Maze (MWM) is an example of an experimental escape
procedure and is commonly used in rats to assess spatial learning and memory (Morris, 1981).
Within the MWM task, the rats are placed within a large circular container of water and trained
to seek refuge on a small platform. This task is spatial, as the unform surface of the water gives
the rats no local cues to use to locate the platform.
If the platform is left in the same location each day, the rat can access its memory of the
task from days prior to more easily escape the water and locate the platform. This is referred to
as a reference memory task. To make the task more difficult and be able to assess learning within
each day (rather than from previous days), the location of the platform can be changed each day.
If the platform’s location is varied on each testing day, the rat must learn that its memory of the
location from previous days is not useful to complete the task on subsequent days. Rather, they
must approach each day without as a novel task with a different ending location. This is referred
to as a working memory task (Vorhees & Williams, 2006).
The MWM task is one way to analyze performance in a spatial navigation task. To
further understand this phenomenon, the brain region associated with these abilities must be
considered. A brain region called the hippocampus has been shown to underly spatial
navigation in both humans and rodents (Schmajuk, 1990; O’Keefe & Nadel, 1979).
Interestingly this region is also responsible for memory formation in both species (Ekstrom et
al., 2003). Within the hippocampus, individual cells, known as place cells, signal the location
of the organism in its environment. These pyramidal cells within the hippocampus become
active when an organism is in a particular location in the environment, commonly referred to as
a place field. Many place fields together create a cognitive representation of the organism’s
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environment that can be used to complete various navigational memory tasks (O'Keefe &
Speakman, 1987).
The hippocampus is a long structure with dorsal and ventral portions (Figure 1) that seem
to have different functions. The dorsal hippocampus is known to play an important role in
spatial, working memory tasks (Lee
& Kesner, 2003). The ventral
hippocampus is known to be
involved with emotion (Fanselow &
Dong, 2010). Previous work in our
lab has shown that the dorsal and
ventral sections within the same
hemisphere work together during
navigation (Lee et al., 2019). The lab
is currently determining how activity

Figure 1: Hippocampus in rats, monkeys, and humans. Note
the elongated structure in all three with dorsal/posterior and
ventral/ anterior regions (Strange et al. 2014)

in the dorsal hippocampus impacts
place cell firing in the ventral hippocampus. We are using a Horseshoe Maze (Oler & Markus,
2000) that has both an emotional (presumably ventral hippocampus) and spatial (presumably
dorsal hippocampus) component. Rather than doing a permanent lesion or temporary
inactivation using a drug such as muscimol, we would like to temporarily inactivate the dorsal
hippocampus with Designer Receptors Exclusively Activated by Designer Drugs (DREADDs).
DREADDs were selected as the inactivation technique because they require minimal
invasiveness and maximal control of the brain area of interest (Smith et al. 2016). This will
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allow for a comparison of the organisms’ behavior and cell activity multiple times with both a
functional and inactivated dorsal hippocampus.
My honor's project was to verify that the procedure for inactivating the dorsal
hippocampus with DREADDS is successful. Since it is well known that an inactivated dorsal
hippocampus impairs spatial memory, it was expected that rats with inactivated dorsal
hippocampi will have more difficulty locating a hidden platform in a water maze. Expected
results include greater amounts of time required and increased swim distances to locate the
platform.

Methods
Subjects
A total of 5 virgin male Fischer’s (F344) rats (Envigo, IN) were used for these
experiments. Two 12-month-old rats were used for the working and reference memory task and
underwent DREADDs surgery and injection trials to analyze the effect of a potential dorsal
hippocampal inactivation. Three additional, 11-month old rats began training on the working
memory task. All rats were handled and tails were marked upon arrival. They were singly housed
for the entirety of the experiment in an environment with a standard 12-hour light/12-hour dark
cycle. They had unlimited access to food and water in their home cages. All rats had no previous
training on other tasks.
Throughout the experiment, the experimenters were blind to whether or not the rats
received drug or vehicle injections to temporarily inactivate the dorsal hippocampus to prevent
bias. All surgeries and injections were successful. The research protocol was approved by the
University of Connecticut IACUC.
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Apparatus
The water maze consisted of a water-filled plastic tub (dimensions: 140cm diameter,
40cm height). A removable clear Plexiglas escape platform (15cm diameter) was submerged
2cm beneath the water’s surface at varying locations each day.
Behavioral Procedures
General Procedure
The rats were trained on the classic
Morris Water Maze task. In this task, the
platform was located 2cm under the surface
of the water. Subjects were run four times
each day, interleaved. Within these four
trials, each rat was placed at 4 different
starting locations in a pseudorandom order,

Figure 2: Example of Morris Water Maze with
the four potential starting locations and
platform marked

always facing the wall, within the water maze. The rats were allowed a maximum swim time
of 60 seconds to locate the hidden platform. If they were unable to locate the platform within
this time, the experimenter guided them to the platform. Once the platform was reached, the
rat was left for on it for 10 seconds. The rat was then removed, dried, and placed in a heated
plastic tub. The location of the platform remained the same on all trials each day. Videos of
all trials were recorded. Latency, or length of time required to reach the platform, was
documented and analyzed during each day.
Reference Memory Task
For the reference memory task subjects, the platform location remained in the location
as shown below for all testing days.
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Figure 3: MWM with the reference
memory platform location marked.

Working Memory Task
For the working memory task subjects, the platform locations were arranged in two
different orientations. For the first part of the experiment, the rat had to locate a platform at
one of eight locations each day, with the location changing from day to day. These locations
are shown in Figure 4a. Due to a possible overtraining effect, the platform locations were
changed to 9 different target locations, as shown in Figure 4b.

Figure 4: a) MWM with the 4 potential starting locations and original eight potential
platform locations marked. b) MWM with the 4 potential starting locations and the
new nine potential platform locations
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DREADDs Procedure

Figure 5: Sequence of training used within this experiment.

As seen in Figure 5, the rats were first trained on the MWM task itself. Once they
demonstrated proficiency (criteria was an average latency under 15 seconds for trials 2-4 for 4
consecutive days), the rats were anesthetized and bilaterally injected with inhibitory
DREADDS into the dorsal hippocampi. After a two-week recovery period, the animals were
reintroduced to the classic MWM task. They were trained until their performance matched
their pre-surgery level.
A low dose of clozapine was injected to
target the DREADDs and inactivate the dorsal
hippocampus. These clozapine injections were
alternated with a vehicle injection (experimenter
blind to the drug condition) on every other day
for a twelve-day period.
Data Analysis Procedure
Each day videos of all trials were
recorded The videos for each trial were analyzed
using an AI program called DeepLabCut in

Figure 6: Screenshot of a rat during one trial
in the Morris Water Maze. The three red rots
on the rat’s nose and ears will be placed on all
videos to be tracked as reference points within
DeepLabCut. Video examples can be found
here.

order to tease apart the rats’ specific behavioral patterns (Mathis et al., 2018). This program
allowed us to measure the amount of time (latency) it took each rat to reach the platform, total
distance travelled, and speed of the rats when in the Morris Water Maze. DeepLabCut was used
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to track the average speeds, distances travelled, and latencies of the rat thought the ten-day
injection period to garner information about whether or not the dorsal hippomcapus had been
successfully inactivated (Figure 6).

Results
Reference Memory Task
Rat 23 was trained to locate a hidden platform in the MWM for many consecutive days.
The location of the platform was changed from day to day at the beginning of the project (pretraining days 1-19 and retraining days 1-27). The rat did not seem to be learning the task, so the
decision was made to transition the task to the simpler reference memory task in which the
location of the platform was the same throughout all trials on all days (Reference 1- onward). For
clarity, only the reference memory task data are shown below. The amount of time, in sections, it
took to locate the platform was recorded for all trials for all rats.
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Figure 7: Latency to hidden platform, in seconds, for the reference memory task over the course of
training. Each day consisted of 4 trials. Gray trials represent the latencies for pre-training before
DREADDS surgery and re-training after DREADDS surgery. Orange trials represent 0.1mg/kg
Clozapine injections. Blue trials represent DMSO/vehicle injections. All highlighted trials indicate the
first trial on each training day. Black dashed line indicated when the subject was switched to the
reference memory task.

The overall training progress of the reference memory rat is shown above in Figure 7. As
can be seen, the latencies of all trials seem to vary not only from day to day, but also from trial to
trial within days. Within a reference memory task, one would expect the latency to reach the
platform to be short if the subject has learned the task, as they can access their memory of the
platform’s location from previous training days. To the right of the blue arrow, there does appear
to be a decreased latency for most of the trials. Within the ten days of MWM reference task
training, there was only one trial (Reference 4, trial 3) that exceeded twenty seconds. This
variation is to be expected, as this data is only showing the performance of one rat. As shown by
the orange and blue latencies above, the latencies of the reference memory rat seemed to differ
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when injections were given. Analysis was conducted in order to further examine potential
differences when the subject received Clozapine and DMSO/vehicle injections.
In order to determine if the injections themselves were causing a change in the physical
abilities of the rat, speed (in centimeters per second) was analyzed.

Speed
25

Repeated Measures
Drug: F(1,4) = 0.796, n.s.
Trial: F(3,12) = 0.942, n.s.
Drug x Trial: F(3,12) = 2.883, p = 0.08 #
No sig pairwise comparisons
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Figure 8: Mean speed travelled in cm/s(+/- SEM) during the vehicle and drug trials
within the reference memory MWM task for all four trials. The blue bars represent
the days in which the rat received vehicle/DMSO injections and the orange bars
represent the days in which the rat received 0.1mg/kg of Clozapine.

A repeated measures ANOVA was performed to determine how the day number and
injection content (drug/vehicle) affected the speed of the rat on all injection days. Ignoring the
effect of the trial number (i.e. first versus second versus third fourth), there was no difference in
the speed of the rats based on the injection they received (i.e. Clozapine or DMSO) (F(1,4) =
0.796 n.s.). As seen in Figure 8, the speed of the reference memory rat was relatively similar if
the rat received DMSO or Clozapine injections. The speeds ranged from 15 to 20 centimeters per
second, regardless of injection contents. This was the desired result, as we hoped that the
injection had no effect on the physical ability of the rat to complete the task.
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Ignoring the effect of the injections’ contents, there was no difference in the speed of the
rats based on the trial number (F(3,12) = 0.942, n.s.). As seen in Figure 8, the speed of the
reference memory rat was relatively similar from trial to trial. During all trials, the rat swam
between about 15 and 20 centimeters per second. This was the desired result, as we hoped that
the injection had no effect on the physical ability of the rat to complete the task.
No interaction was found between the trial number and injection contents. (F(3,12) =
2.883, p = 0.08#). This suggests that whether or not a rat received Clozapine or DMSO on did
not affect the speed of the rat when trying to locate the hidden platform within a given trial.
Given the trending p-value (0.08), this interaction may have become significant if the rat
received more injections and there was more data to be analyzed.
In order to determine if the injections caused a change in the spatial navigation of the rat,
distance (in centimeters) travelled to the platform was analyzed.

Distance
600
Repeated Measures
Drug: F(1,4) = 0.818, n.s.
Trial: F(3,12) = 0.574, n.s.
Drug x Trial: F(3,12) = 2.85, p = 0.082 #
No sig pairwise comparisons
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Figure 9: Mean distance travelled in centimeters (+/- SEM) during the vehicle and
drug trials within the reference memory MWM task for all four trials. The blue bars
represent the days in which the rat received vehicle injections and the orange bars
represent the days in which the rat received 0.1mg/kg of Clozapine. For reference,
the maze is about 3m in diameter.
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A repeated measures ANOVA was performed to determine how the day number and
injection content (drug/vehicle) affected the distance the rat traveled during each trial on all
injection days. Ignoring the effect of the trial number (i.e. first versus second versus third fourth),
there was no difference in the distance travelled by the rat based on the injection they received
(i.e. Clozapine or DMSO) (F(1,4) = 0.818 n.s.). As seen in Figure in Figure 9, the distance
travelled by the reference memory rat was relatively similar when the rat received DMSO or
Clozapine injections. When the rat received DMSO or Clozapine, it travelled about 200cm.
Ignoring the effect of the injections’ contents, there was no difference in the distance
travelled by the rat based on the trial number (F(3,12) = 0.574, n.s.). As seen in Figure 9, the
distance travelled by the reference memory rat was relatively similar from trial to trial.
No interaction was found between the trial number and injection contents. (F(3,12) =
2.85, p = 0.082#). This suggests that whether or not the rat received Clozapine or DMSO on did
not affect the distanced travelled to locate the hidden platform within a given trial. Given the
trending p-value (0.082), this interaction may have become significant if the rat received more
injections and there was more data to be analyzed.
To further understand the great difference in distance travelled on the first trial for both
vehicle and Clozapine injections, the relationship was further investigated. To complete the first
trial each day, the rat must access its memory from previous training days to remember the
location of the trial. On all subsequent trials, the rat can access this memory, but can also relearn
the platform location, making these trials potentially different in terms of distance travelled.
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Distance -- Trial 1 vs. Average Trials 2-4
600
Repeated Measures
Drug: F(1,4) = 2.822, n.s.
Trial: F(3,12) = 0.403, n.s.
Drug x Trial: F(3,12) = 4.260, n.s.
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Figure 10: Mean distance travelled in centimeters (+/- SEM) during the vehicle and
drug trials for the first and average of second through fourth trials within the
reference memory MWM task. The blue bars represent the days in which the rat
received vehicle injections and the orange bars represent the days in which the rat
received 0.1mg/kg of Clozapine. For reference, the maze is about 3m in diameter.

A repeated measures ANOVA was performed to determine how the day number and
injection content (drug/vehicle) affected the distance the rat traveled during the first trial and all
subsequent trials on all injection days. Ignoring the effect of the trial number (i.e. first versus
second versus third fourth), there was no difference in the distance travelled by the rat based on
the injection they received (i.e. Clozapine or DMSO) (F(1,4) = 2.822, n.s.). As seen in Figure 10,
the distance travelled by the reference memory rat was relatively similar when the rat received
DMSO or Clozapine injections. When the rat received DMSO or Clozapine, it travelled about
between 200 and 250cm.
Ignoring the effect of the injections’ contents, there was no difference in the distance
travelled by the rat based on the trial number (F(1,4) = 0.403, n.s.).
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No interaction was found between the trial number and injection contents. (F(1,4) =
4.260, n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not
affect the distanced travelled to locate the hidden platform on either the first or second through
fourth trials.
Additionally, in order to determine if the injections caused a change in the spatial
navigation of the rat, latency to the platform (in seconds) was analyzed.

Latency
35

Repeated Measures
Drug: F(1,4) = 0.803, n.s.
Trial: F(3,12) = 0.558, n.s.
Drug x Trial: F(3,12) = 2.691, p = 0.093 #
No sig pairwise comparisons
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Figure 11: Mean latency elapsed in seconds (+/- SEM) during the vehicle and drug
trials within the reference memory MWM task for all four trials. The blue bars
represent the days in which the rat received vehicle injections and the orange bars
represent the days in which the rat received 0.1mg/kg of Clozapine.

A repeated measures ANOVA was performed to determine how the day number and
injection content (drug/vehicle) affected the time it took the rat to reach the platform during each
trial on all injections days. Ignoring the effect of the trial number (i.e. first versus second versus
third fourth), there was no difference in the latency to the platform based on the injection they
received (i.e. Clozapine or DMSO) (F(1,4) = 0.803 n.s.). As seen in Figure in Figure 11, the
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latencies were relatively similar when the rat received DMSO or Clozapine injections. When the
rat received DMSO or Clozapine, it took about 10-12 seconds to locate the hidden platform.
Ignoring the effect of the injections’ contents, there was no difference in the distance
travelled by the rat based on the trial number (F(3,12) = 0.558, n.s.). As seen in Figure 11, the
latencies were relatively similar from trial to trial.
No interaction was found between the trial number and injection contents. (F(3,12) =
2.691, p = 0.093#). This suggests that whether or not a rat received Clozapine or DMSO on did
not affect the length of time it took the rat to locate the hidden platform within a given trial.
Given the trending p-value (0.093), this interaction may have become significant if the rat
received more injections and there was more data to be analyzed.
To further understand the great difference in latency between the latency to the platform
on the first trial for both vehicle and Clozapine injections, the relationship was further
investigated. To complete the first trial each day, the rat must access its memory from previous
training days to remember the location of the trial. On all subsequent trials, the rat can access this
memory, but can also relearn the platform location, making these trials potentially different in
terms of latency to the platform.
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Repeated Measures
Drug: F(1,4) = 2.348, n.s.
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Figure 12: Mean latency elapsed in seconds (+/- SEM) during the vehicle and drug
trials for the first and average of second through fourth trials within the reference
memory MWM task. The blue bars represent the days in which the rat received
vehicle injections and the orange bars represent the days in which the rat received
0.1mg/kg of Clozapine.

A repeated measures ANOVA was performed to determine how the trial number and
injection content (drug/vehicle) affected the time it took the rat to reach the platform during the
first trial and all subsequent trials on all injections days. Ignoring the effect of the trial number
(i.e. first versus second versus third fourth), there was no difference in the latency to the platform
based on the injection they received (i.e. Clozapine or DMSO) (F(1,4) = 2.348, n.s.). As seen in
Figure in Figure 12, the latencies were relatively similar when the rat received DMSO or
Clozapine injections. When the rat received DMSO or Clozapine, it took about 10-12 seconds to
locate the hidden platform.
Ignoring the effect of the injections’ contents, there was no difference in the distance
travelled by the rat based on the trial number (F(1,4) = 0.378, n.s.).
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No interaction was found between the trial number and injection contents. (F(1,4) =
3.727, n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not
affect the length of time it took the rat to locate the hidden platform on either the first or second
through fourth trials.
Behavioral analysis highlighted that there was no effect of Clozapine on the speed,
distance travelled, and latency to the platform for rat #23, contrary to expectations. If more data
was collected, whether or not a rat received Clozapine or DMSO on may have affected the
distance travelled and length of time it took the rat to locate the hidden platform within a given
trial.
After the training protocol was completed, the reference memory rat was perfused and the
brain was sectioned and stained. The resulting images of the hippocampus were analyzed in
order to determine if the initial DREADDs surgery was successful.
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Figure 13: Histological analysis of fluorescent virus spread in the dorsal hippocampus of the
reference memory subject. Blue regions are DAPI stain to target all cell bodies. Pink regions
indicate the parts of the dorsal hippocampus that were successfully injected with the DREADDs
virus. Top and bottom panels show two different images from the same subject (top: dorsal anterior,
bottom: dorsal posterior) Note: injections were bilateral.
As seen in Figure 13, the DREADDs virus reached certain parts of the dorsal
hippocampus within the reference memory subject. Pink-colored areas were found to be very
pronounced within the CA1 and CA3 regions of the right dorsal hippocampus, indicating that the
DREADDs were successfully delivered to these areas. A fainter pink color on the left dorsal
hippocampus indicates that some DREADDs virus reached this area, but less than what reached
the right dorsal hippocampus.
Histological analysis explained the lack of effect from Clozapine injections. Since the
virus did not reach entire dorsal hippocampus, Clozapine injections could not completely
inactivate this brain region. When Clozapine was injected, rat #23 could still use the active parts
of its dorsal hippocampus to complete the MWM task.
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Figure 14: Latency to hidden platform, in seconds, for the working memory task over the course of
training. Each day consisted of 4 trials. Gray trials represent the latencies for pre-training before
DREADDS surgery and re-training after DREADDS surgery. All highlighted trials indicate the first
trial on each training day. Orange trials represent 0.1mg/kg Clozapine injections. Blue trials represent
DMSO/vehicle injections.

The overall training progress of the working memory rat (#24) is shown above in Figure
14. As can be seen, the latencies of all trials seem to vary not only from day to day, but also from
trial to trial within days. Within a working memory task, one would expect the latency for the
first trial of each day to be long, as the rat must “forget” the platform location from the previous
training day and search for the platform’s new location. On subsequent trials on the same day,
the rat is expected to take less time to locate the platform, as they can access their memory of the
platform’s location from the first trial.
As shown by the orange and blue latencies above, the latencies of the working memory
rat seemed to differ when injections were given. Analysis was conducted in order to further
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examine potential differences when the subject received Clozapine and DMSO/vehicle
injections.
Each day videos of all trials were recorded. DeepLabCut was then used to track the
average speeds, distances travelled, and latencies of the rat thought the ten day injection period.
In order to determine if the injections themselves were causing a change in the physical abilities
of the rat, speed (in centimeters per second) was analyzed.

Speed
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Repeated Measures
Drug: F(1,3) = 1.167, n.s.
Trial: F(3,9) = 2.151, n.s.
Drug x Trial: F(3,9) = 1.233, n.s.
No sig pairwise comparisons
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Figure 15: Mean speed travelled in cm/s(+/- SEM) during the vehicle and drug trials
within the working memory MWM task for all four trials. The blue bars represent
the days in which the rat received vehicle/DMSO injections and the orange bars
represent the days in which the rat received 0.1mg/kg of Clozapine.

A repeated measures ANOVA was performed to determine how the day number and
injection content (drug/vehicle) affected the speed of the rat on all injection days. Ignoring the
effect of the trial number (i.e. first versus second versus third fourth), there was no difference in
the speed of the rats based on the injection they received (i.e. Clozapine or DMSO) (F(1,4) =
1.167, n.s.). As seen in Figure in Figure 15, the speed of the reference memory rat was relatively
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similar if the rat received DMSO or Clozapine injections. The speeds were about 20 centimeters
per second, regardless of injection contents. This was the desired result, as we hoped that the
injection had no effect on the physical ability of the rat to complete the task.
Ignoring the effect of the injections’ contents, there was no difference in the speed of the
rats based on the trial number (F(3,9) = 2.151, n.s.). As seen in Figure 15, the speed of the
reference memory rat was relatively similar from trial to trial. During all trials, the rat swam
between about 20 centimeters per second. This was the desired result, as we hoped that the
injection had no effect on the physical ability of the rat to complete the task.
No interaction was found between the trial number and injection contents. (F(3,9) =
1.233, n.s.) This suggests that whether or not a rat received Clozapine or DMSO on did not affect
the speed of the rat when trying to locate the hidden platform within a given trial.
In order to determine if the injections caused a change in the spatial navigation of the
working memory rat, distance (in centimeters) travelled to the platform was analyzed.
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Repeated Measures
Drug: F(1,3) = 1.325, n.s.
Trial: F(3,9) = 4.342, p < 0.05*
Drug x Trial: F(3,9) = 1.643, n.s.
No sig pairwise comparisons
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Figure 16: Mean distance travelled in centimeters (+/- SEM) during the vehicle and
drug trials within the working memory MWM task for all four trials. The blue bars
represent the days in which the rat received vehicle injections and the orange bars
represent the days in which the rat received 0.1mg/kg of Clozapine. For reference,
the maze is about 3m in diameter.

A repeated measures ANOVA was performed to determine how the trial number and
injection content (drug/vehicle) affected the distance the rat traveled during each trial on all
injection days. Ignoring the effect of the trial number (i.e. first versus second versus third fourth),
there was no difference in the distance travelled by the rat based on the injection they received
(i.e. Clozapine or DMSO) (F(1,4) = 1.325, n.s.). As seen in Figure 16, the distance travelled by
the working memory rat was relatively similar when the rat received DMSO or Clozapine
injections. When the rat received DMSO or Clozapine, it travelled about 500cm during the first
trial and about 150cm during trials 2-4.
Ignoring the effect of the injections’ contents, there was a difference in the distance
travelled by the rat based on the trial number (F(3,12) = 4.342, p<0.05) As seen in Figure 16, the
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distance travelled by the working memory rat was different from trial to trial. The working
memory subject travelled about 500cm during the first trial and about 150cm during trials 2-4.
No interaction was found between the trial number and injection contents. (F(3,12) =
1.643, n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not
affect the distanced travelled to locate the hidden platform within a given trial.
Additionally, in order to determine if the injections caused a change in the spatial
navigation of the rat, latency to the platform (in seconds) was analyzed.

Latency
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Repeated Measures
Drug: F(1,3) = 1.134, n.s.
Trial: F(3,9) = 2.252, n.s.
Drug x Trial: F(3,9) = 1.27, n.s.
No sig pairwise comparisons
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Figure 17: Mean latency elapsed in seconds (+/- SEM) during the vehicle and drug
trials within the working memory MWM task for all four trials. The blue bars
represent the days in which the rat received vehicle injections and the orange bars
represent the days in which the rat received 0.1mg/kg of Clozapine.

A repeated measures ANOVA was performed to determine how the day number and
injection content (drug/vehicle) affected the time it took the rat to reach the platform during each
trial on all injections days. Ignoring the effect of the trial number (i.e. first versus second versus
third fourth), there was no difference in the latency to the platform based on the injection they
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received (i.e. Clozapine or DMSO) (F(1,4) = 1.134, n.s.). As seen in Figure in Figure 17, the
latencies were relatively similar when the rat received DMSO or Clozapine injections. When the
rat received DMSO or Clozapine, it took about 30 seconds to locate the platform during the first
trial and about 7 seconds during trials 2-4.
Ignoring the effect of the injections’ contents, there was no difference in the distance
travelled by the rat based on the trial number (F(3,9) = 2.252, n.s.). As seen in Figure 17, the
latencies were relatively similar from trial to trial. The working memory subject took about 30
seconds to locate the platform during the first trial and about 7 seconds during trials 2-4.
No interaction was found between the trial number and injection contents. (F(3,9) = 1.27,
n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not affect the
length of time it took the rat to locate the hidden platform within a given trial.
Behavioral analysis highlighted that there was no effect of Clozapine on the speed,
distance travelled, and latency to the platform for rat #24, contrary to expectations.
After the training protocol was completed, the working memory rat was perfused and the
brain was sectioned and stained. The resulting images of the hippocampus were analyzed in
order to determine if the initial DREADDs surgery was successful.
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Figure 18: Histological analysis of fluorescent virus spread in the dorsal
hippocampus of the working memory subject. Blue regions are DAPI stain to
target all cell bodies. Pink regions indicate the parts of the dorsal hippocampus
that were successfully injected with the DREADDs virus. Top and bottom panels
show two different images from the same subject (top: dorsal anterior, bottom:
dorsal posterior). Note: injections were bilateral.

As seen in Figure 18, the DREADDs virus did not reach the entire dorsal hippocampus.
Pink-colored areas were found within the left CA3 and part of the left CA1 regions. Little to no
virus seems to have reached the right dorsal hippocampus.
Histological analysis explained the lack of effect from Clozapine injections. Since the
virus did not reach entire dorsal hippocampus, Clozapine injections could not completely
inactivate this brain region. When Clozapine was injected, rat #23 could still use the active parts
of its dorsal hippocampus to complete the MWM task.
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In order to further understand the effectiveness of the DREADDs inactivation
mechanism, three more subjects have been trained on the working memory task. The location of
the hidden platform was changed each day for rats 27 through 29.

Latency Across Days for New Working Memory Rat #27
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Figure 19: Latency to hidden platform, in seconds, for the working memory task over the course of
the first seven days of training. Each day consisted of 4 trials. All highlighted trials indicate the first
trial on each training day.

The first seven days of training for the first working memory rat, rat #27, are shown
above in Figure 19. As can be seen, the latencies of all trials seem to vary not only from day to
day, bit also from trial to trial within days. Within a working memory task, one would expect the
latency for the first trial of each day to be long, as the rat must “forget” the platform location
from the previous training day and search for the platform’s new location. On subsequent trials
on the same day, the rat is expected to take less time to locate the platform, as they can access
their memory of the platform’s location from the first trial.
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As seen in Figure 19, there appears to be a variability in the amount of time it took rat
#27 to reach the platform during trials 2-4. For example, it took 60 seconds to locate the platform
on the second trial of Day 1 and 2 of training, but less than 5 seconds on the second trial of Day
3. This could be a result of the increased and decreased distances between the alternating starting
locations and the hidden platform’s location. If the rat is placed at the starting location very close
to the platform, it may require less time to complete the trial. If the rat is placed far from the
platform location, it may require more time.
To determine the significance of this variability and to assess the proficiency of the rat, a
repeated measures ANOVA was performed to determine how the trial number affected the time
it took the rat to reach the platform during the first trials and all subsequent trials on all training
days (trial 1 vs. average trials 2-4). There was a decrease in the amount of time taken to find the
hidden platform on trials 2-4 relative to trial 1 (F(1,4) = 6.657, p< 0.005). As seen in Figure 19,
the latencies for trials 2-4 appear to be less than the latencies for trial 1.
The same protocol and analysis was completed for a second rat.

29

Latency Across Days for New Working Memory Rat #28
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Figure 20: Latency to hidden platform, in seconds, for the working memory task over the course of
the first seven days of training. Each day consisted of 4 trials. All highlighted trials indicate the first
trial on each training day.

The first seven days of training for rat #28 are shown above in Figure 20. The same
results were expected for this rat as were for the rat discussed previously. As seen in Figure 20,
there appears to be a variability in the amount of time it took rat #28 to reach the platform during
trials 2-4. For example, it took 60 seconds to locate the platform on the fourth trial of Day 1 and
about 5 seconds during the fourth trial on Day 3. This could be a result of the increased and
decreased distances between the alternating starting locations and the hidden platform’s location.
If the rat is placed at the starting location very close to the platform, it may require less time to
complete the trial. If the rat is placed far from the platform location, it may require more time.
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To determine the significance of this variability and to assess the proficiency of the rat, a
repeated measures ANOVA was performed to determine how the trial number affected the time
it took the rat to reach the platform during the first trials and all subsequent trials on all training
days (trial 1 vs. average trials 2-4). There was a decrease in the amount of time taken to find the
hidden platform on trials 2-4 relative to trial 1 (F(1,4) = 621.255, p< 0.005). As seen in Figure
20, the latencies for trials 2-4 appear to be less than the latencies for trial 1.
The same protocol and analysis was completed for a third rat.

Latency Across Days for New Working Memory Rat #29
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Figure 21: Latency to hidden platform, in seconds, for the working memory task over the
course of the first seven days of training. Each day consisted of 4 trials. All highlighted trials
indicate the first trial on each training day.

The first seven days of training for rat #29 are shown above in Figure 21. The same
results were expected for this rat as were for the rats discussed previously. As seen in Figure 21,
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there appears to be a variability in the amount of time it took rat #29 to reach the platform during
trials 2-4. For example, it took about 45 seconds to locate the platform on the fourth trial of Day
1 and about 10 seconds during the fourth trials on Day 3 and 4. This could be a result of the
increased and decreased distances between the alternating starting locations and the hidden
platform’s location. If the rat is placed at the starting location very close to the platform, it may
require less time to complete the trial. If the rat is placed far from the platform location, it may
require more time.
To determine the significance of this variability and to assess the proficiency of the rat, a
repeated measures ANOVA was performed to determine how the trial number affected the time
it took the rat to reach the platform during the first trials and all subsequent trials on all training
days (trial 1 vs. average trials 2-4). There was no change in the amount of time taken to find the
hidden platform on trials 2-4 relative to trial 1 (F(1,4) = 0.166, n.s.). As seen in Figure 21, there
does not appear to be any relative trend in the latencies for trial 1 and trials 2-4. Rather than
seeing a progressive decrease as trials progress, the length of time the rat required to reach the
platform varies, suggesting that more training is required in order to move forward with
DREADDs surgery, the next step in the training protocol.

Discussion
The reference and working memory water maze tasks provide different ways to assess
whether or not the entire bilateral dorsal hippocampus has been inactivated in the subjects. Since
both are known to assess spatial navigation in rats (Jarrard, 1993) the assets and drawbacks of
both tasks can be assessed. The reference memory task is a simpler, less complex task. This task
requires activation of existing spatial memory acquired throughout training. Since the platform
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remains in the same location each day, the task requires less training. The subject must
remember the location of the platform from previous training days, and simply find that location.
Thus, the reference memory subjects can reach proficiency in a shorter period of time.
On the other hand, the working memory task is innately more complex. Since the
platform is moved to different locations on each training day, the subject must “forget” the
location of the platform from the previous training day and, instead, search for the platform’s
adjusted location during the first trial and “remember” this new location during the second
through fourth trials. As opposed to being able to activate existing spatial memories in a
reference memory task, subjects must perform a spatial learning task when completing a
working memory task. Because of this increased complexity, the working memory task requires
a longer training period and some rats are unable to learn this task.
Overall, the working memory task should be a better way to assess whether or not the
dorsal hippocampus has been inactivated. Its complexity requires the subject to treat each
training day as a new learning experience, thus requiring an active the dorsal hippocampus to
locate the adjusted platform location, rather than simply a memory of the location from previous
training days.
Reference Memory Task
It was expected that Clozapine injections would activate the DREADDs within the dorsal
hippocampus of the reference memory task rat, causing impaired social navigation. If the
DREADDs were successfully activated by Clozapine, there would have been a difference in the
spatial navigation abilities of the rat to complete the reference memory task.
Behavioral analysis during injection trials showed that there was no change in the speed
following either vehicle or Clozapine injection (Figure 8). During all trials, the rat swam at a
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speed of about 15 to 20 centimeters per second, regardless of the injections contents (Figure 8).
This was expected, and allowed us to conclude that either the drug and/or the injection did not
cause any change in the physical abilities of the rat, thus allowing us to move forward and
analyze the distances and latencies during all injection days.
It was expected that there would be an increase in distance travelled by the reference
memory rat when Clozapine was injected, as the drug was expected to target the DREADDs and
inactivate the dorsal hippocampus. However, there was no effect of the Clozapine on the distance
travelled by the reference memory rat (Figures 9&10). The distance travelled by the reference
memory rat was about 200cm when the rat received DMSO or Clozapine injections (Figure 9)
suggesting that the dorsal hippocampus had not been successfully inactivated.
A large variation in the distance travelled during the first trial was found both between
the DMSO and Clozapine injection days and within all Clozapine injection days (Figure 9). This
could have been a result of increased and decreased distances between the alternating starting
locations and the hidden platform’s location. If the rat is placed at the starting location very close
to the platform, it may need to swim a decreased distance to locate the platform. If the rat is
placed far from the platform location, it may need to swim a greater distance.
Similarly, it was expected that there would be an increase in the amount of time to locate
the hidden platform for the reference memory rat when Clozapine was injected, as the drug was
expected to target the DREADDs and inactivate the dorsal hippocampus. However, there was no
effect of the Clozapine on the latency for the reference memory subject (Figures 11&12). When
the rat received DMSO or Clozapine, it took about 10-12 seconds to locate the hidden platform
(Figure 11), suggesting that the dorsal hippocampus had not been successfully inactivated.
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A large variation in the latencies during the first trial was found both between the DMSO
and Clozapine injection days and within all Clozapine injection days (Figure 11). This could
have been a result of increased and decreased distances between the alternating starting locations
and the hidden platform’s location. If the rat is placed at the starting location very close to the
platform, it may require less time to complete the trial. If the rat is placed far from the platform
location, it may require more time.
Findings were also analyzed using the histology garnered after perfusion. The DREADDs
virus seemed to reach a significant portion of the bilateral dorsal hippocampus within this subject
(Figure 13). However, the amount of virus that reached each region seemed to vary, thus
potentially leaving some spatial navigation abilities intact, confirming the lack of effect found
from Clozapine injections on distance travelled and latency to the hidden platform (Figures
9&11).
Working Memory Task
Expectations for the working memory task were similar to the reference memory task, as
they are both commonly used to assess spatial navigation in rats. If the DREADDs were
successfully activated by Clozapine, there would have been a difference in the spatial navigation
abilities of the rat to complete the working memory task. It was expected that Clozapine
injections would activate the DREADDs within the dorsal hippocampus of the working memory
task rat, causing impaired social navigation.
Behavioral analysis during injection trials showed that there was no change in the speed
following either vehicle or Clozapine injection (Figure 15). During all trials, the rat swam at a
speed of about 20 centimeters per second, regardless of the injections contents (Figure 15). This
was expected, and allowed us to conclude that either the drug and/or the injection did not cause
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any change in the physical abilities of the rat, thus allowing us to move forward and analyze the
distances and latencies during all injection days.
It was expected that there would be an increase in distance travelled by the working
memory rat when Clozapine was injected, as the drug was expected to target the DREADDs and
inactivate the dorsal hippocampus. However, there was no effect of the Clozapine on the distance
travelled by the reference memory rat (Figure 16). The distance travelled by the reference
memory rat was about relatively similar when the rat received DMSO or Clozapine injections -500cm during the first trial and about 150cm during trials 2-4 (Figure 16). This greatest distance
on the first trial and decreasing distances on the second through fourth trials are expected given
the working memory task in which the platform’s location changes each day.
Similarly, it was expected that there would be an increase in the amount of time to locate
the hidden platform for the working memory rat when Clozapine was injected, as the drug was
expected to target the DREADDs and inactivate the dorsal hippocampus. However, there was no
effect of the Clozapine on the latency for the reference memory subject (Figure 17). When the rat
received DMSO or Clozapine, it took about 30 seconds to locate the platform during the first
trial and about 7 seconds during trials 2-4 (Figure 17), suggesting that the dorsal hippocampus
had not been successfully inactivated. This greatest latency on the first trial and decreasing
latencies on the second through fourth trials are expected given the working memory task in
which the platform’s location changes each day.
Findings were also analyzed using the histology garnered after perfusion. The DREADDs
virus seemed to reach the left CA3 and part of the left CA1 regions of the dorsal hippocampus
(Figure 18). Given that the virus did not seem to reach the entire bilateral dorsal hippocampus,
some spatial navigation abilities could have been left intact, confirming the lack of effect found
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from Clozapine injections on distance travelled and latency to the hidden platform (Figures
16&17).
For the three additional working memory rats, it was expected that the length of time
required to locate the hidden platform would be greatest during the first trial each day and
decrease for trials 2-4 as the rats could use their memory of the platform’s location from the first
trial to help locate it on subsequent trials. The first two working memory rats exhibited this
expected behavior (Figure 19&20, p< 0.005). This suggest that the rats are learning the task
correctly and are becoming proficient. If trends continue, DREADDs surgery can be completed
and the rat can move forward through the training protocol. However, the third working memory
rat did not exhibit such a trend, as there was no difference in the latencies for trial 1 and the
average of trials 2-4 (Figure 21). This suggests that this rat has not properly learned the task, and
thus requires more training before DREADDs surgery can be completed.
Future Directions
Given the lack of successful inactivation with these two subjects, this project will
continue with more subjects. More rats will be trained on the MWM task until they are
proficient, and an adjusted DREADDs surgery protocol will be used to bilaterally inject
inhibitory DREADDs into their dorsal hippocampi.
Once complete inactivation of the dorsal hippocampus is achieved, the same drug
delivery mechanism used within this task will then be used in the Horseshoe Maze (Oler &
Markus, 2000). Since the Horseshoe maze is more complex than the water maze and the effects
of dorsal hippocampus impairments on the water maze are well known, the results of the
inactivation will allow us to confirm the effectiveness of the drug delivery mechanism to be used
within the more complex task.
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